Discover how comprehensive spend management revamps 4 critical operations areas.
Healthcare organizations aren’t falling short because of a lack of expertise; they’re constrained by fragmented operating models.
Across pharmacy, supply chain, capital equipment, and purchased services decisions are still made in silos. That structure limits visibility, slows execution and leaves most performance potential untapped. In fact, most organizations capture only 26% of their total optimization opportunity under a fragmented operating model.
Across pharmacy, supply chain, capital equipment, and purchased services decisions are still made in silos. That structure limits visibility, slows execution and leaves most performance potential untapped. In fact, most organizations capture only 26% of their total optimization opportunity under a fragmented operating model.
-
1. Specialty drug cost control through coordinated action
Specialty drug decisions often occur in isolation, missing downstream impacts on equipment, supplies and operations. An integrated approach connects pharmacy, capital equipment and supply chain in real time. When a drug is evaluated, related equipment is standardized, supplies are consolidated and implementation is aligned across departments. This coordinated execution accelerates timelines and expands savings beyond pharmacy alone, delivering two to three times greater value while improving consistency across the full episode of care.
-
2. Capital planning with full system visibility
Capital investments are typically evaluated at the equipment level, overlooking systemwide costs such as supplies, staffing and facility changes. Integrated spend management models total cost of ownership upfront by connecting data across departments. This ensures that all dependencies are identified before approval, improving decision accuracy. Organizations can avoid costly surprises by preventing an average of $2.3 million in hidden costs per major acquisition, while making more confident, strategic capital allocation decisions.
-
3. Predictive supply chain resilience
Supply disruptions are often managed reactively, leading to higher costs and operational strain. Integrated intelligence connects signals across categories to identify risks earlier. This enables coordinated action such as early sourcing, therapeutic adjustments and broader vendor negotiations before disruptions escalate. By shifting from reactive to proactive management, organizations reduce emergency purchasing and maintain leverage, achieving up to 40% lower disruption costs and strengthening overall supply chain resilience.
-
4. Margin protection without compromising quality
Cost-reduction efforts executed in silos can unintentionally impact quality, clinician satisfaction and operations. Integrated spend management enables systemwide scenario modeling that evaluates both financial and clinical outcomes before decisions are made. Organizations can identify savings strategies that minimize disruption while avoiding those that create risk. This approach ensures financial targets are met without compromising care quality, improving alignment across stakeholders and delivering more sustainable margin improvement.